← Eichor
Study identifier: NCT05627219 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network

Condition: Metastatic Prostate Carcinoma · Stage IIIB Prostate Cancer AJCC v8 · Stage IIIC Prostate Cancer AJCC v8  ·  Sponsor: Thomas Jefferson University

PhaseN/A
Planned participants30
Who can joinMale, 18 Years to no upper limit
Healthy volunteersYes

About this study

This trial evaluates whether a network of peer genetic coaches is useful for addressing disparities in genetic testing and screening among African American men with prostate cancer that has spread from where it first started (primary site) to other places in the body (metastatic). While genetic testing has become central to prostate cancer care, African American men are less likely seek testing due to lack of awareness, cultural beliefs, financial limitations, fear of discrimination, and mistrust in the healthcare system. A network of peer genetic coaches may help address barriers, beliefs, and needs of African American men in the community and provide navigation to increase engagement in genetic testing.

This description comes directly from the study's public registry record.

Talk to the study team

Amy Leader, DrPh, MPH  ·  215 955-7739  ·  amy.leader@jefferson.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityPhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05627219